The Up/Down ratio for the final month of Q4 reporting is 1.65. As with the “final” readings of the two previous quarters, this is the best figure recorded in four years. The level and trajectory of the vignette strongly suggests that no economic recession is on the near-term horizon.

• Read more

March’s downdraft shaved a point off of our median Small Cap P/E multiple and about a point-and-a-half off the Large Cap measure. The Ratio of Ratios thus moved a tick closer to its long-term average but remains in the tight range of contemporary results.

• Read more

Value style boxes outperformed Growth by 8-10% across the capitalization spectrum.

• Read more

For Q1, the Equal Weighted S&P 500 eked out a small gain (+1%). Much more impressive was its performance relative to the index’s Top 10 (-11%). This is the widest quarterly gap in favor of the average stock since Q4-22.

• Read more

The Up/Down ratio for the second month of Q4 reporting is 1.80. Aside from a slight hiccup last spring, this Up/Down work has consistently grown for the past nine quarters. The vignette has now reached a level that has previously been very difficult to maintain, especially since the GFC.

• Read more

The equal-weighted S&P 500’s +4% return in February outperformed the S&P 600’s +2%, pushing the Ratio of Ratio’s valuation gap to its widest margin since September 2024. A declining P/E multiple for the median Small Cap in our L3000 universe was also at play, migrating from 21.4x to 20.0x.

• Read more

Since Halloween, RB Value (+14%) has dominated RB Growth (-7%); it was the best four-month stretch for RB Value relative to RB Growth since April 2022. During that time, the change in valuation is unmistakable—with Large Value now much less of a bargain.

• Read more

On a total return basis, the S&P 500’s February loss of 0.8% was its first monthly decline since last April. However, the equal-weighted S&P 500 advanced 3.5%. The resulting performance gap, in favor of the average stock, is the largest since April 2009, when the market blasted off the GFC lows.

• Read more

The first Up/Down ratio for Q4 is 2.63. Once again, this is another new high for the “one-month” ratio measured back to the amazing earnings growth following the 2020 EPS washout. Given the results of the past three quarters, this “contemporary record” storyline in our Up/Down work is feeling repetitive.

• Read more

Despite all the talk about Small Caps ripping higher, the Ratio of Ratios narrowed only 1%. The S&P 600 (best SC proxy for this vignette) started 2026 off with a 5.6% gain. The Equal Weighted S&P 500 (best LC proxy), advanced 3.3%.

• Read more

Since Halloween, RB Value (+12%) has been on a tear compared to RB Growth (-5%)—the best three-month stretch for RB Value relative to RB Growth since the start of 2022.

• Read more

The Equal Weighted S&P 500 (+3.4%) had its best month versus the S&P 500 Top 10 Index (-0.9%)since March 2025. Poor results coming from MSFT (-11%), AAPL (-5%), and Broadcom (-4%) dragged down the once bulletproof Top 10. The average stock in the S&P 500 has now outperformed the largest ten for three consecutive months, with David beating Goliath by 8.5% during that span.

• Read more

The final Up/Down ratio for Q3 is 1.61—the highest “three-month” figure since Q2-21, and the second consecutive above-average reading. Our survey of around 5,000 firms continues to point to an EPS growth story that has extended to the most firms since the economic bounce following the pandemic.

• Read more

Our Ratio of Ratios continued its never-ending sideways trek in 2025, ending the year right at its four-year moving average. We enter 2026 with this vignette advising that Small Caps can be purchased at a steep discount to Large Caps (just like the last six years).

• Read more

Royal Blue Value surged 10% and 8% in the last two quarters of 2025, nearly doubling the annual return of RB Growth (+16%).

• Read more

After barely dodging a bear market decline in April, the S&P 500 proceeded to surge 39% through year end. The Mag Seven stocks followed the same pattern in exaggerated form. All seven names ended 2025 in positive territory, but contributed much less to overall performance than the previous two years. Still, their effect over the past three years is overwhelming: S&P Top Ten Index +188% vs. the Equal Weighted S&P 500 +43%.

• Read more

The latest Up/Down ratio is 1.64—the second consecutive above-average reading for this vignette. Since the GFC, outperforming quarters have most commonly appeared in chunks of four or five. Still, for now, the story of EPS-growth expansion continues to gain steam.

• Read more

It’s been five long years since Small Caps had their last sustained relative-strength rally: From November 2020 through March 2021, the S&P 600 gained an astounding 51% versus the S&P 500’s +22%.

• Read more

Last month, Royal Blue Value (+3.5%) outdid RB Growth (-4.1%) for the first time since April 2022. Over the last two years, Royal Blue Growth is up 52%, just a bit more than Royal Blue Value’s gain of 51%.

• Read more

Five of the Magnificent Seven firms ended November in the red. Despite that turbulence at the top, the S&P 500 still managed to eke out a gain for the seventh-consecutive month. The valiant November effort from the index’s 2025 underdogs—Value, High Dividend, Low Volatility, and Equal Weight—won’t change much in the final assessment of the year.

• Read more